Members of the public may attend this meeting in person at the address printed above or remotely via the options listed below. Call to Order Roll Call Discussion of ICOC Chair, ICOC Vice-chair, and ...

CIRM is governed by 35 dedicated Californians representing patients, researchers and the biotechnology industry whose knowledge, passion and commitment to CIRM’s mission has guided the organization ...

Jonathan Thomas, PhD, JD, is President and CEO of the California Institute for Regenerative Medicine (CIRM). Thomas was previously the Chair of the CIRM governing Board from June 2011 to March 2023.

Las reuniones de la CFAOC están organizadas por la Oficina del Contralor del Estado. A continuación, se incluye una copia de la agenda publicada en https://www.sco ...

David Higgins, PhD, earned his PhD in molecular biology and genetics from the University of Rochester in New York, followed by a postdoctoral fellowship at the National Cancer Institute before moving ...

一种由抑制性神经元组成的细胞治疗产品，可以在脑外伤后迁移、整合和恢复神经功能。 近 6 万美国人（包括 700,000 万加州人）因脑外伤而患有永久性的身体或心理健康问题，但目前尚无治疗 ...

If you would like to contact CIRM regarding questions you may have about employment opportunities, please contact us at [email protected]. CIRM encourages job seekers to apply for specific job openings ...

San Francisco, CA – California’s stem cell agency, the California Institute for Regenerative Medicine (CIRM) today approved $150 million in new funding to help move promising stem cell-based therapies ...

Our Agency funds clinical trials testing promising stem cell or gene therapies for currently incurable diseases or disorders to help patients with unmet medical needs. For basic information about stem ...

这篇综述的重点是染色体末端的帽子（称为端粒）如何保护染色体并保持其稳定。端粒的丢失会导致染色体不稳定，从而导致许多 DNA 改变，从而导致癌症或遗传病。端粒丢失或端粒功能丧失 ...

have the ability to divide and create an identical copy of themselves, a process called self-renewal; and can also divide to form cells that mature into cells that make up every type of tissue and ...

The California Institute for Regenerative Medicine (CIRM) is funding regenerative medicine and gene therapy research to improve the lives of Sickle Cell patients in California and the world. Sickle ...